Cardinal Health 301, LLC, a prominent subsidiary of Cardinal Health, Inc., is headquartered in the United States and operates extensively across North America. Founded in 1971, the company has established itself as a key player in the healthcare industry, focusing on the distribution of pharmaceuticals and medical products. With a commitment to enhancing patient care, Cardinal Health 301 offers a diverse range of services, including supply chain management and healthcare solutions tailored to meet the needs of hospitals and healthcare providers. Its unique approach combines innovative technology with a deep understanding of the healthcare landscape, positioning the company as a trusted partner in the sector. Recognised for its operational excellence, Cardinal Health 301 continues to achieve significant milestones, solidifying its market position as a leader in healthcare distribution and services.
How does Cardinal Health 301, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cardinal Health 301, LLC's score of 70 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Cardinal Health 301, LLC, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Cardinal Health, Inc., which may influence its climate commitments and performance metrics. While Cardinal Health 301, LLC lacks direct emissions data, it is important to note that its parent company, Cardinal Health, Inc., has established various climate initiatives. However, specific reduction targets or achievements for Cardinal Health 301, LLC are not detailed in the available information. The absence of documented reduction targets suggests that the company may still be in the process of developing its climate strategy. As a subsidiary, Cardinal Health 301, LLC may align its climate commitments with those of Cardinal Health, Inc., which participates in initiatives such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to promote transparency and accountability in corporate climate action. In summary, while Cardinal Health 301, LLC does not currently provide specific emissions data or reduction targets, it is positioned within a corporate structure that may influence its future climate commitments and performance.
Access structured emissions data, company-specific emission factors, and source documents
| 2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
Cardinal Health 301, LLC's Scope 3 emissions, which increased by 5% last year and increased significantly since 2018, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 93% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cardinal Health 301, LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.